References
- Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–e596.
- Fitch K, Lau J, Engel T, et al. The cost impact to Medicare of shifting treatment of worsening heart failure from inpatient to outpatient management settings. Clinicoecon Outcomes Res. 2018;10:855–863.
- Butler J, Yang M, Manzi MA, et al. Clinical course of patients with worsening heart failure with reduced ejection fraction. J Am Coll Cardiol. 2019;73(8):935–944.
- Butler J, Djatche LM, Sawhney B, et al. Clinical and economic burden of chronic heart failure and reduced ejection fraction following a worsening heart failure event. Adv Ther. 2020;37(9):4015–4032.
- Ambrosy AP, Fonarow GC, Butler J, et al. The global health and economic burden of hospitalizations for heart failure: lessons learned from hospitalized heart failure registries. J Am Coll Cardiol. 2014;63(12):1123–1133.
- Okumura N, Jhund PS, Gong J, et al. Importance of clinical worsening of heart failure treated in the outpatient setting: evidence from the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF). Circulation. 2016;133(23):2254–2262.
- Rame JE, Sheffield MA, Dries DL, et al. Outcomes after emergency department discharge with a primary diagnosis of heart failure. Am Heart J. 2001;142(4):714–719.
- DeVore AD, Hammill BG, Sharma PP, et al. In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization. J Am Heart Assoc. 2014;3(4):e001088.
- America’s Health Insurance Plans (AHIP) Center for Policy and Research. Innovations in Reducing Preventable Hospital Admissions, Readmissions, and Emergency Room Use. 2010. Available from: http://docshare01.docshare.tips/files/26469/264694950.pdf
- Teigland C, Pulungan Z, Shah T, et al. As it grows, medicare advantage is enrolling more low-income and medically complex beneficiaries. The Commonwealth Fund. 2020.
- CMS. Medicare shared savings program: Accountable Care Organization (ACO) 2018. quality measures. Published online 2018 [cited 2020 October 29]. Available from: https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/sharedsavingsprogram/Downloads/2018-reporting-year-narrative-specifications.pdf
- Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation. 2012;125(1):e2–e220.
- Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–619.
- Jacobson G, Freed M, Damico AA. Dozen facts about Medicare advantage in 2019 Published 2019 June 6 [cited 2020 October 9]. Available from: https://www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage-in-2019/
- U.S. Bureau of Labor Statistics. How BLS measures price change for medical care services in the consumer price index [cited 2020 August 28]. Available from: https://www.bls.gov/cpi/factsheets/medical-care.htm#A2
- CMS. Health plans – general information [cited 2020 October 15]. Available from: https://www.cms.gov/Medicare/Health-Plans/HealthPlansGenInfo
- Allen LA, Smoyer Tomic KE, Wilson KL, et al. The inpatient experience and predictors of length of stay for patients hospitalized with systolic heart failure: comparison by commercial, Medicaid, and Medicare payer type. J Med Econ. 2013;16(1):43–54.
- Allen LA, Smoyer Tomic KE, Smith DM, et al. Rates and predictors of 30-day readmission among commercially insured and Medicaid-enrolled patients hospitalized with systolic heart failure. Circ Heart Fail. 2012;5(6):672–679.
- CMS. Medicare 2020 Part C & D star ratings technical notes. Published online 2019. Available from: https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovGenIn/Downloads/Star-Ratings-Technical-Notes-Oct-10-2019.pdf